|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Cell Biol. 10.1083/jcb.200602125
Sturge et al.
• Figure S1 Endo180 siRNA treatment or ROCK inhibition reduces MLC2 phosphorylation in osteosarcoma cells.
• Figure S2 Knock down of Endo180 but not uPAR results in a rear tail retraction defect and reduced MLC2 phosphorylation.
• Figure S3 Endo180-mediated cell migration is independent of the extracellular matrix.
• Figure S4 Endo180 siRNA treatment does not affect levels of MLC2 regulatory kinases.
• Figure S5 Characterization of Endo180 transfected MCF7 cells.
• Video 1 Control siRNA-treated MG63 cells.
• Video 2 Endo180 siRNA-treated MG63 cells.
• Video 3 ROCK inhibitor-treated MG63 cells.
| ||||||||||||||||||||||||||
|
|
